See more : PT Mulia Boga Raya Tbk (KEJU.JK) Income Statement Analysis – Financial Results
Complete financial analysis of HCA Healthcare, Inc. (HCA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HCA Healthcare, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Stuhini Exploration Ltd. (STU.V) Income Statement Analysis – Financial Results
- baby calendar Inc. (7363.T) Income Statement Analysis – Financial Results
- TFBS Bioscience Inc. (6939.TWO) Income Statement Analysis – Financial Results
- Hire Technologies Inc. (HIRRF) Income Statement Analysis – Financial Results
- Danske Invest Nye Markeder Obligationer (DKINMOBL.CO) Income Statement Analysis – Financial Results
HCA Healthcare, Inc. (HCA)
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 64.97B | 60.23B | 58.75B | 51.53B | 51.34B | 46.68B | 43.61B | 41.49B | 39.68B | 36.92B | 34.18B | 33.01B | 32.51B | 30.68B | 30.05B | 28.37B | 26.86B | 25.48B | 24.46B | 23.50B | 21.81B | 19.73B | 17.95B | 16.67B | 16.66B | 18.68B | 18.82B | 19.91B | 17.70B | 11.13B | 10.25B | 761.60M | 461.00M | 272.60M |
| Cost of Revenue | 55.34B | 9.37B | 9.48B | 8.37B | 8.48B | 7.72B | 7.32B | 6.93B | 6.64B | 6.26B | 5.97B | 5.72B | 5.18B | 4.96B | 16.83B | 4.62B | 4.40B | 4.32B | 4.13B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.51B | 230.50M | 135.30M | 81.30M |
| Gross Profit | 9.63B | 50.86B | 49.27B | 43.16B | 42.86B | 38.95B | 36.30B | 34.56B | 33.04B | 30.66B | 28.21B | 27.30B | 27.33B | 25.72B | 13.23B | 23.75B | 22.46B | 21.16B | 20.33B | 23.50B | 21.81B | 19.73B | 17.95B | 16.67B | 16.66B | 18.68B | 18.82B | 19.91B | 17.70B | 11.13B | 6.74B | 531.10M | 325.70M | 191.30M |
| Gross Profit Ratio | 14.82% | 84.44% | 83.86% | 83.76% | 83.48% | 83.45% | 83.23% | 83.29% | 83.27% | 83.04% | 82.53% | 82.68% | 84.07% | 83.83% | 44.01% | 83.72% | 83.64% | 83.04% | 83.13% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 65.74% | 69.73% | 70.65% | 70.18% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 29.49B | 27.69B | 26.78B | 23.87B | 23.56B | 21.43B | 20.06B | 18.90B | 18.12B | 16.64B | 15.65B | 15.09B | 13.44B | 12.48B | 11.96B | 11.44B | 10.71B | 10.41B | 9.93B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 29.49B | 27.69B | 26.78B | 23.87B | 23.56B | 21.43B | 20.06B | 18.90B | 18.12B | 16.64B | 15.65B | 15.09B | 13.44B | 12.48B | 11.96B | 11.44B | 10.71B | 10.41B | 9.93B | 9.42B | 8.68B | 7.95B | 7.28B | 6.64B | 6.75B | 7.81B | 7.63B | 7.84B | 7.10B | 0.00 | 4.76B | 452.00M | 283.40M | 162.20M |
| Other Expenses | 0.00 | 14.12B | 12.81B | 12.03B | 12.08B | 10.89B | -466.00M | -430.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 45.44B | 41.81B | 39.59B | 35.90B | 35.64B | 32.31B | 30.24B | 28.36B | 27.08B | 25.09B | 23.42B | 22.48B | 22.99B | 21.56B | 9.19B | 20.82B | 19.31B | 18.08B | 17.43B | 20.80B | 19.01B | 17.68B | 15.73B | 15.45B | 14.79B | 16.86B | 17.65B | 16.76B | 15.34B | 9.62B | 5.36B | 490.30M | 305.90M | 174.10M |
| Cost & Expenses | 55.34B | 51.18B | 49.07B | 44.27B | 44.12B | 40.04B | 37.56B | 35.29B | 33.71B | 31.35B | 29.39B | 28.20B | 28.17B | 26.52B | 26.02B | 25.44B | 23.70B | 22.40B | 21.55B | 20.80B | 19.01B | 17.68B | 15.73B | 15.45B | 14.79B | 16.86B | 17.65B | 16.76B | 15.34B | 9.62B | 8.87B | 720.80M | 441.20M | 255.40M |
| Interest Income | 0.00 | 1.74B | 1.57B | 1.58B | 1.82B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.94B | 1.74B | 1.57B | 1.58B | 1.82B | 1.76B | 1.69B | 1.71B | 1.67B | 1.74B | 1.85B | 1.80B | 2.04B | 2.10B | 1.99B | 2.02B | 2.22B | 955.00M | 655.00M | 563.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.08B | 2.97B | 2.85B | 2.72B | 2.60B | 2.28B | 2.13B | 1.97B | 1.90B | 1.82B | 1.75B | 1.68B | 1.47B | 1.42B | 1.43B | 1.42B | 1.43B | 1.39B | 1.37B | 1.25B | 1.11B | 1.01B | 1.05B | 1.03B | 1.09B | 1.25B | 1.24B | 1.16B | 981.00M | 609.00M | -599.00M | -38.30M | -22.50M | -11.90M |
| EBITDA | 12.72B | 13.29B | 14.25B | 9.74B | 9.66B | 9.37B | 8.20B | 8.48B | 7.53B | 7.04B | 6.55B | 6.37B | 7.06B | 5.75B | 5.07B | 4.61B | 4.83B | 4.21B | 4.36B | 3.95B | 4.04B | 3.08B | 3.29B | 2.43B | 3.30B | 18.68B | 2.85B | 4.31B | 3.33B | 2.12B | 2.07B | 21.40M | 3.90M | 11.40M |
| EBITDA Ratio | 19.58% | 20.03% | 21.52% | 19.48% | 19.20% | 19.17% | 18.88% | 19.81% | 19.95% | 20.12% | 19.23% | 19.78% | 18.65% | 19.12% | 18.16% | 14.51% | 17.07% | 17.54% | 16.04% | 16.88% | 18.52% | 15.60% | 18.69% | 14.60% | 19.82% | 19.93% | 15.89% | 21.64% | 18.84% | 19.02% | 20.17% | 2.81% | 0.85% | 4.18% |
| Operating Income | 9.63B | 9.10B | 9.79B | 7.32B | 7.26B | 6.64B | 6.10B | 6.25B | 6.01B | 5.61B | 4.82B | 4.85B | 4.60B | 4.45B | 4.03B | 2.70B | 3.16B | 3.08B | 2.55B | 2.72B | 2.93B | 2.07B | 2.31B | 1.40B | 2.21B | 2.48B | 1.75B | 3.15B | 2.35B | 1.51B | 2.67B | 59.70M | 26.40M | 23.30M |
| Operating Income Ratio | 14.82% | 15.10% | 16.66% | 14.20% | 14.14% | 14.23% | 13.99% | 15.07% | 15.15% | 15.19% | 14.10% | 14.70% | 14.14% | 14.49% | 13.42% | 9.52% | 11.76% | 12.08% | 10.42% | 11.56% | 13.42% | 10.48% | 12.85% | 8.40% | 13.25% | 13.25% | 9.32% | 15.84% | 13.29% | 13.55% | 26.01% | 7.84% | 5.73% | 8.55% |
| Total Other Income/Expenses | -1.92B | -473.00M | 155.00M | -1.83B | -1.97B | -1.31B | -1.68B | -1.39B | -1.96B | -1.96B | -1.62B | -1.92B | -777.00M | -1.93B | -1.80B | -1.77B | -1.76B | -974.00M | -577.00M | -743.00M | -771.00M | -594.00M | -720.00M | -16.04B | -15.21B | -15.81B | -783.00M | -456.00M | -930.00M | -277.00M | -415.00M | 1.90M | 5.20M | -3.70M |
| Income Before Tax | 7.71B | 8.58B | 9.83B | 5.43B | 5.24B | 5.34B | 4.38B | 4.81B | 3.96B | 3.48B | 2.95B | 2.89B | 3.56B | 2.23B | 2.00B | 941.00M | 1.19B | 1.66B | 2.15B | 1.97B | 2.16B | 1.46B | 1.51B | 516.00M | 1.23B | 1.08B | 388.00M | 2.52B | 1.78B | 1.23B | 969.00M | 42.70M | 25.00M | 13.50M |
| Income Before Tax Ratio | 11.86% | 14.24% | 16.74% | 10.54% | 10.22% | 11.43% | 10.04% | 11.59% | 9.97% | 9.43% | 8.62% | 8.77% | 10.95% | 7.27% | 6.66% | 3.32% | 4.43% | 6.52% | 8.79% | 8.40% | 9.89% | 7.37% | 8.38% | 3.10% | 7.37% | 5.79% | 2.06% | 12.63% | 10.05% | 11.06% | 9.45% | 5.61% | 5.42% | 4.95% |
| Income Tax Expense | 1.62B | 1.75B | 2.11B | 1.04B | 1.10B | 946.00M | 1.64B | 1.38B | 1.26B | 1.11B | 950.00M | 888.00M | 719.00M | 658.00M | 627.00M | 268.00M | 316.00M | 625.00M | 725.00M | 727.00M | 824.00M | 622.00M | 602.00M | 297.00M | 570.00M | 549.00M | 206.00M | 1.01B | 715.00M | 486.00M | 394.00M | 16.80M | 9.80M | 3.70M |
| Net Income | 5.24B | 5.64B | 6.96B | 3.75B | 3.51B | 3.79B | 2.22B | 2.89B | 2.13B | 1.88B | 1.56B | 1.61B | 2.47B | 1.21B | 1.05B | 673.00M | 874.00M | 1.04B | 1.42B | 1.25B | 1.33B | 833.00M | 886.00M | 219.00M | 657.00M | 379.00M | -305.00M | 1.51B | 961.00M | 630.00M | 507.00M | 25.50M | 15.20M | 9.80M |
| Net Income Ratio | 8.07% | 9.37% | 11.84% | 7.28% | 6.83% | 8.11% | 5.08% | 6.97% | 5.37% | 5.08% | 4.55% | 4.86% | 7.58% | 3.93% | 3.51% | 2.37% | 3.25% | 4.07% | 5.82% | 5.30% | 6.11% | 4.22% | 4.94% | 1.31% | 3.94% | 2.03% | -1.62% | 7.56% | 5.43% | 5.66% | 4.95% | 3.35% | 3.30% | 3.60% |
| EPS | 19.24 | 19.44 | 21.51 | 11.10 | 10.27 | 11.04 | 6.33 | 7.80 | 5.34 | 4.46 | 3.54 | 3.62 | 5.17 | 2.83 | 3.08 | 1.97 | 2.56 | 2.57 | 3.24 | 2.62 | 2.66 | 1.63 | 1.69 | 0.39 | 1.12 | 0.73 | -0.46 | 2.24 | 1.44 | 1.80 | 1.05 | 0.78 | 0.61 | 0.55 |
| EPS Diluted | 18.96 | 19.15 | 21.16 | 10.93 | 10.07 | 10.66 | 5.95 | 7.30 | 4.99 | 4.16 | 3.37 | 3.49 | 4.97 | 2.76 | 3.02 | 1.93 | 2.51 | 2.53 | 3.18 | 2.58 | 2.61 | 1.59 | 1.65 | 0.39 | 1.11 | 0.73 | -0.46 | 2.22 | 1.43 | 1.80 | 1.03 | 0.78 | 0.61 | 0.55 |
| Weighted Avg Shares Out | 272.40M | 290.35M | 323.32M | 338.27M | 341.21M | 342.90M | 350.09M | 370.54M | 398.74M | 420.48M | 439.60M | 443.20M | 476.61M | 426.42M | 341.93M | 341.93M | 341.93M | 403.40M | 440.02M | 475.62M | 500.75M | 511.04M | 524.26M | 748.72M | 660.71M | 645.21M | 663.04M | 671.88M | 667.36M | 350.00M | 482.86M | 32.69M | 24.92M | 17.82M |
| Weighted Avg Shares Out (Dil) | 276.41M | 294.67M | 328.75M | 343.61M | 348.23M | 355.30M | 372.22M | 395.85M | 426.72M | 450.35M | 461.91M | 459.40M | 495.94M | 437.35M | 348.71M | 348.71M | 348.71M | 410.21M | 447.50M | 483.66M | 510.34M | 523.90M | 536.97M | 748.72M | 666.67M | 645.21M | 663.04M | 677.93M | 672.03M | 516.67M | 492.23M | 32.69M | 24.92M | 17.82M |
4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates
Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.
Can HCA Healthcare (HCA) Beat Q2 Earnings on Growing Admissions?
HCA Healthcare's (HCA) second-quarter earnings are likely to benefit from improved admissions and payer mix, partially offset by rising operating expenses.
HCA Healthcare (HCA) Reports Next Week: Wall Street Expects Earnings Growth
HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever
These healthcare businesses are booming. Vertex Pharmaceuticals is raking in approvals, cash, and profits.
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
Over the years, especially the past three, I have become more cautious about the technology sector's blatant overvaluation. Nevertheless, it is difficult to ignore the capabilities of companies such as Nvidia (NASDAQ: NVDA ) and their innovative solutions for AI.
4 GARP Stocks to Scoop up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. BAP, BAH, HUBB and HCA are some stocks that hold promise.
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging population, technological advances, and rising healthcare costs provide the sector with a compelling combination of...
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
5 Stocks Worth a Look From Leading Sectors This Earnings Season
Apple (AAPL), HCA Healthcare (HCA), Expro International (XPRO), Churchill Downs (CHDN) and JPMorgan Chase (JPM) could make great plays as the second-quarter earnings season unfolds.
Will HCA (HCA) Beat Estimates Again in Its Next Earnings Report?
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Source: https://incomestatements.info
Category: Stock Reports